p53调控骨髓瘤细胞CD46表达及麻疹病毒感染
本研究用37个细胞系和23份原代样本评估骨髓瘤细胞对溶瘤麻疹病毒(MV)的敏感性及其与p53的关系。感染和细胞死亡与CD46表达相关,CD46表达与TP53状态相关;TP53异常细胞系高表达CD46且优先被MV感染(P = .046和P = .045)。原代骨髓瘤细胞较正常细胞过表达CD46并被MV高效感染和杀伤。p53通路激活剂nutlin3a在p53功能正常的细胞中抑制CD46表达和MV感染,但在p53缺陷细胞中无此作用,后者对MV高度敏感。作者认为这些结果支持针对p53缺陷患者的MV临床试验。
要点
- TP53异常细胞系较TP53野生型高表达CD46且优先被MV感染(P = .046和P = .045)。
- 骨髓瘤细胞感染完全依赖CD46表达,原代骨髓瘤细胞过表达CD46并被MV高效感染和杀伤。
- nutlin3a在p53功能正常的原代骨髓瘤细胞中抑制CD46表达和MV感染,但在p53缺陷细胞中无此作用。
核心结论
- 骨髓瘤细胞对MV高度敏感,p53缺陷骨髓瘤细胞中p53通路对MV感染的抑制作用被解除。
- 作者认为这些结果支持针对p53缺陷患者的MV临床试验。
研究设计与样本
- 研究使用37个骨髓瘤细胞系和23份原代样本,评估骨髓瘤细胞对溶瘤麻疹病毒(MV)的敏感性与p53的关系。
主要发现
- 感染和细胞死亡与CD46表达相关,CD46表达与TP53状态相关。
- TP53异常细胞系高表达CD46,且较TP53野生型细胞系优先被MV感染(P = .046和P = .045)。
- 骨髓瘤细胞(细胞系和原代细胞)的感染完全依赖CD46表达。
- 在TP53野生型细胞系而非TP53异常细胞系中,nutlin3a激活p53通路抑制CD46表达和MV感染,而TP53沉默则反向增加CD46表达和MV感染。
- p53染色质免疫沉淀实验和microRNA评估显示CD46基因表达受p53直接和间接调控。
临床怎么用
- 作者认为这些结果支持针对p53缺陷患者的MV临床试验。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In this study, we assessed the sensitivity of myeloma cells to the oncolytic measles virus (MV) in relation to p53 using 37 cell lines and 23 primary samples. We showed that infection and cell death were correlated with CD46 expression, which was associated with TP53 status; TP53 abn cell lines highly expressed CD46 and were preferentially infected by MV when compared with the TP53 wt cell lines (P = .046 and P = .045, respectively). Infection of myeloma cells was fully dependent on CD46 expression in both cell lines and primary cells. In the TP53 wt cell lines, but not the TP53 abn cell lines, activation of the p53 pathway with nutlin3a inhibited both CD46 expression and MV infection, while TP53 silencing reciprocally increased CD46 expression and MV infection. We showed using a p53 chromatin immunoprecipitation assay and microRNA assessment that CD46 gene expression was directly and indirectly regulated by p53. Primary myeloma cells overexpressed CD46 as compared with normal cells and were highly infected and killed by MV. CD46 expression and MV infection were inhibited by nutlin3a in primary p53-competent myeloma cells, but not in p53-deficient myeloma cells, and the latter were highly sensitive to MV infection. In summary, myeloma cells were highly sensitive to MV and infection inhibition by the p53 pathway was abrogated in p53-deficient myeloma cells. These results argue for an MV-based clinical trial for patients with p53 deficiency.
引用
- Lok A, Descamps G, Tessoulin B, et al. p53 regulates CD46 expression and measles virus infection in myeloma cells. Blood Adv. 2018. PMID: 30530776. doi:10.1182/bloodadvances.2018025106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。